封面
市場調查報告書
商品編碼
1327877

全球醫療保健 BPO 市場

Healthcare BPO

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 397 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,醫療保健 BPO 全球市場將達到 5834 億美元

在不斷變化的後 COVID-19 商業環境中,全球醫療保健 BPO 市場預計 2022 年為 2851 億美元,預計到 2030 年將達到 5834 億美元,2022-2030 年分析期間的年複合成長率預計將成長9.4 %。提供商服務是本報告分析的細分市場之一,預計年複合成長率10.5%,到分析期結束時將達到 2167 億美元。鑑於疫情后的持續復甦,未來八年支付服務行業的年複合成長率已調整為 9.2%。

美國市場預計將成長1204億美元,中國年複合成長率為10.7%

到 2022 年,美國醫療保健 BPO 市場預計將達到 1204 億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到346億美元,2022年至2030年的分析期間年複合成長率為10.7%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 8.9% 和 7.9%。在歐洲,德國預計年複合成長率約為 9.5%。

受訪企業示例

  • IBM Corporation
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd.
  • HCL Technologies Ltd.
  • Tata Consultancy Services Ltd.
  • Charles River Laboratories International, Inc.
  • Labcorp Drug Development
  • Tata Group
  • Concentrix Corporation
  • Genpact Ltd.
  • Hexaware Technologies Ltd.
  • Sykes Enterprises, Inc.
  • GeBBS Healthcare Solutions, Inc.
  • Catalent, Inc.
  • IQVIA

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP12285

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Healthcare BPO Market to Reach $583.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Healthcare BPO estimated at US$285.1 Billion in the year 2022, is projected to reach a revised size of US$583.4 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2022-2030. Provider Service, one of the segments analyzed in the report, is projected to record a 10.5% CAGR and reach US$216.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Payer Service segment is readjusted to a revised 9.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $120.4 Billion, While China is Forecast to Grow at 10.7% CAGR

The Healthcare BPO market in the U.S. is estimated at US$120.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$34.6 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Select Competitors (Total 61 Featured) -

  • IBM Corporation
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd.
  • HCL Technologies Ltd.
  • Tata Consultancy Services Ltd.
  • Charles River Laboratories International, Inc.
  • Labcorp Drug Development
  • Tata Group
  • Concentrix Corporation
  • Genpact Ltd.
  • Hexaware Technologies Ltd.
  • Sykes Enterprises, Inc.
  • GeBBS Healthcare Solutions, Inc.
  • Catalent, Inc.
  • IQVIA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
    • Outlook
    • Segment Review
    • Healthcare BPO - Global Key Competitors Percentage Market Share in 2022 (E)
    • Leading Players in the Global Contract Research Outsourcing Market by Revenue Share (in %): 2019
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Accenture Plc (Ireland)
    • Boehringer Ingelheim (Germany)
    • Catalent Pharma Solutions, Inc. (USA)
    • Conduent, Inc. (USA)
    • Covance, Inc. (USA)
    • Charles River Laboratories International, Inc. (USA)
    • Cognizant Technology Solutions Corporation (USA)
    • EXLService Holdings, Inc. (USA)
    • GeBBS Healthcare Solutions, Inc. (USA)
    • Genpact Limited (India)
    • HCL Technologies Limited (India)
    • Infosys BPM Limited (India)
    • IQVIA (USA)
    • Lonza Group AG (Switzerland)
    • PAREXEL International Corp. (USA)
    • Syneos Health (USA)
    • Tata Consultancy Services Limited (India)
    • Wipro Limited (India)
    • WNS Global Services Ltd. (India)
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Healthcare Costs to Drive Inclination towards BPO Services
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Aging Population Burdens an Already Strained Healthcare System: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
    • Regulatory Challenges Inflate the Demand for Healthcare BPO
    • ICD-10 Coding Standards and Impending Adoption of ICD-11 Standards: Potential for BPO Providers
    • With Many Benefits of Cloud Computing, "The Cloud" Comes With a Silver Lining for BPO Service Providers Struggling to Remain Cost Competitive in the Era of Value Based Care
    • Inherent Advantages of Cloud Computing Make "The Cloud" a Game Changer in the Healthcare BPO Industry: Benefits of Cloud Measured in % Efficiency Improvements & Cost Reduction
    • Revenue Cycle Management Outsourcing Maximize Revenue Collection Operations
    • Global Market for Revenue Cycle Management: Revenues in US$ Billion for the Years 2018, 2020, 2022 and 2024
    • Reimbursement Changes Amplify Demand
    • Rise in Healthcare Industry Consolidation Boosts Growth Opportunities
    • Select M&A Deals Involving Large Healthcare Firms
    • Healthcare BPO Market for Pharma Sector
    • Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2020
    • Patent Cliffs in Pharma Industry Drive Dependence on BPO Providers
    • Major Pharma Drugs Losing Patents in 2019
    • Healthcare Analytics Services Address the Challenge of High Data Volumes
    • Industry Witnesses a Surge in Near Shore Outsourcing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Provider Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Payer Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pharmaceutical Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Healthcare BPO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Rise in Healthcare Costs Trigger the Need for Healthcare BPO Services
    • Changing Regulations in the US: Implications for the Payer BPO Market
    • Rising Healthcare Costs Drive Healthcare Reforms in the US: Per Capita Healthcare Expenditure (in $) for the Period 2014-2019
    • Health Coverage in the US: Percentage Breakdown of Number of Americans Covered by Source of Health Coverage for the Years 2018 and 2028
    • Healthcare Reforms Lead to Reduced Uninsured Population: Percentage of Uninsured Population for the Period 2008, 2010, 2012, 2014, 2016 and 2018
    • Number of Medicare ACOs in the US for the Years 2012 through 2018
    • Market Analytics
    • TABLE 14: USA Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • JAPAN
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • CHINA
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Chinese Healthcare Industry on a Growth Trajectory
    • Market Analytics
    • TABLE 23: China Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: China 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • EUROPE
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • FRANCE
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: France 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • GERMANY
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Indian BPO Industry Revolutionizes Healthcare Sector
    • Market Analytics
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2023 & 2030

IV. COMPETITION